Latest Breaking News On - Ionis pharmaceuticals inc - Page 16 : comparemela.com

Ionis Pharmaceuticals (IONS) Appoints Kyle Jenne as Chief Global Product Strategy Officer

Ionis Pharmaceuticals (IONS) Appoints Kyle Jenne as Chief Global Product Strategy Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Onaiza cadoret manierKyle jennePraecis pharmaceuticalsIonis pharmaceuticals incSchering ploughKing pharmaceuticalsAcorda therapeuticsIonis pharmaceuticals

Ionis announces new chief global product strategy officer to lead next phase of commercial growth

Ionis announces new chief global product strategy officer to lead next phase of commercial growth
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Kyle jenneOnaiza cadoret manierPraecis pharmaceuticalsIonis pharmaceuticals incIonis pharmaceuticalsAcorda therapeuticsKing pharmaceuticalsSchering plough

Ionis announces new chief global product strategy officer to lead next phase of commercial growth

Ionis announces new chief global product strategy officer to lead next phase of commercial growth
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Onaiza cadoret manierKyle jenneIonis pharmaceuticalsAcorda therapeuticsKing pharmaceuticalsIonis pharmaceuticals incPraecis pharmaceuticalsSchering plough

Ionis to present at upcoming investor conferences

CARLSBAD, Calif., Feb. 28, 2024 /PRNewswire/ Ionis Pharmaceuticals, Inc. today announced that management will participate in fireside chats at the following investor conferences: .

Health care conference onIonis pharmaceuticalsIonis pharmaceuticals incPrnewswire ionis pharmaceuticals incAnnual health care conference

Biogen s positive step for ALS and neuromuscular disease patients

Biogen Inc. has announced a significant advancement in the treatment of amyotrophic lateral sclerosis (ALS), commonly known as motor neuron disease (MND).

Region flamandePriya singhalPhilip van dammeDrug administrationNeuromuscular reference centerIonis pharmaceuticals incEuropean medicines agencyEuropean commissionUniversity hospital leuvenEuropean unionCommittee for medicinal products human useMedicinal productsHuman useRatings scale revisedIonis pharmaceuticalsClinical development